98-10404. International Drug Scheduling; Convention on Psychotropic Substances; Dihydroetorphine, Ephedrine, and Remifentanil; Isomers of Psychotropic Substances  

  • [Federal Register Volume 63, Number 76 (Tuesday, April 21, 1998)]
    [Notices]
    [Page 19735]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-10404]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 98N-0148]
    
    
    International Drug Scheduling; Convention on Psychotropic 
    Substances; Dihydroetorphine, Ephedrine, and Remifentanil; Isomers of 
    Psychotropic Substances
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice; correction.
    
    -----------------------------------------------------------------------
    
        The Food and Drug Administration (FDA) is correcting a notice that 
    appeared in the Federal Register of March 18, 1998 (63 FR 13258). The 
    document announced an upcoming World Health Organization review of 
    three substances. The document was published with an error. This 
    document corrects that error.
    
    FOR FURTHER INFORMATION CONTACT: Nicholas P. Reuter, Office of Health 
    Affairs (HFY-20), Food and Drug Administration, 5600 Fishers Lane, 
    Rockville, MD 20857, 301-827-1696, E-mail: NReuter@bangate.fda.gov.
    
        In FR Doc. 98-6910, beginning on page 13258 in the Federal Register 
    of Wednesday, March 18, 1998, the following correction is made:
        1. On page 13259, in the first column, in the fourth full 
    paragraph, the second sentence ``Remifentanil is approved in the United 
    States as an anesthetic for use in animals and is controlled 
    domestically as a narcotic in schedule II of the CSA.'' is corrected to 
    read as follows: ``Remifentanil is approved in the United States as an 
    anesthetic and is controlled domestically as a narcotic in schedule II 
    of the CSA.''
    
        Dated: April 14, 1998.
    William K. Hubbard,
    Associate Commissioner for Policy Coordination.
    [FR Doc. 98-10404 Filed 4-20-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
04/21/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice; correction.
Document Number:
98-10404
Pages:
19735-19735 (1 pages)
Docket Numbers:
Docket No. 98N-0148
PDF File:
98-10404.pdf